Chlamydia Research Today is a free monthly online journal that collates and summarizes the latest research about Chlamydia, including details on symptoms, diagnosis, treatment, causes, problems.

Volume 2 (2005), Issue 2 (February)

1. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.
   Nat Rev Immunol, 5(2): 149-61. [Abstract] [Full-text]
2. Impact of patient characteristics on performance of nucleic acid amplification tests and DNA probe for detection of Chlamydia trachomatis in women with genital infections.
   J Clin Microbiol, 43(2): 577-84. [Abstract] [Full-text]
3. Can we evaluate population screening strategies in UK general practice? A pilot randomised controlled trial comparing postal and opportunistic screening for genital chlamydial infection.
   J Epidemiol Community Health, 59(3): 198-204. [Abstract] [Full-text]
4. Idiopathic scrotal elephantiasis.
   Urology, 65(2): 389. [Abstract] [Full-text]
5. Giant scrotal elephantiasis.
   Urology, 65(2): 389. [Abstract] [Full-text]
6. Catalytic mechanism of Chlamydia trachomatis flavin-dependent thymidylate synthase.
   J Biol Chem, 280(7): 5456-67. [Abstract] [Full-text]
7. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.
   J Infect Dis, 191(6): 917-23. [Abstract] [Full-text]
8. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study.
   J Infect Dis, 191(6): 907-16. [Abstract] [Full-text]
9. Identification of networks of sexually transmitted infection: a molecular, geographic, and social network analysis.
   J Infect Dis, 191(6): 899-906. [Abstract] [Full-text]
10. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection.
    N Engl J Med, 352(7): 676-85. [Abstract] [Full-text]
11. Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia.
    Clin Microbiol Infect, 11(3): 240-2. [Abstract] [Full-text]
12. Data collection for sexually transmitted disease diagnoses: a comparison of self-report, medical record reviews, and state health department reports.
    Ann Epidemiol, 15(3): 236-42. [Abstract] [Full-text]
13. Activity of cathelicidin peptides against Chlamydia spp.
    Antimicrob Agents Chemother, 49(3): 1201-2. [Abstract] [Full-text]
14. Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazil.
    Antimicrob Agents Chemother, 49(3): 1120-6. [Abstract] [Full-text]
15. Emergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis.
    Antimicrob Agents Chemother, 49(3): 903-7. [Abstract] [Full-text]
16. Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species.
    Infect Immun, 73(3): 1868-72. [Abstract] [Full-text]
17. Degradation of the proapoptotic proteins Bik, Puma, and Bim with Bcl-2 domain 3 homology in Chlamydia trachomatis-infected cells.
    Infect Immun, 73(3): 1861-4. [Abstract] [Full-text]
18. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
    Infect Immun, 73(3): 1568-77. [Abstract] [Full-text]
19. Broad degradation of proapoptotic proteins with the conserved Bcl-2 homology domain 3 during infection with Chlamydia trachomatis.
    Infect Immun, 73(3): 1399-403. [Abstract] [Full-text]
20. Chlamydial antibodies and risk of prostate cancer.
    Cancer Epidemiol Biomarkers Prev, 14(2): 385-9. [Abstract] [Full-text]
21. Sexual behavior survey and screening for chlamydia and gonorrhea in university students in South Korea.
    Int J Urol, 12(2): 187-93. [Abstract] [Full-text]

© 2004-2008 Chlamydia Research Today. All Rights Reserved.